Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Cancer Panel

NCT03558165 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03558165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03558165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Cancer Panel
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
February 18, 2022
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer stage iv